Press Release

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Telmisartan Market to Grow at a CAGR of 3.5% during 2021-2026, Aided by the Rising Use of the Drug in the Treatment for COVID-19 Infected Patients

According to a new report by EMR titled, ‘Global Telmisartan Market Report and Forecast 2021-2026’, the market attained a value of about USD 3,574 million in 2020. The industry is further expected to grow at a CAGR of 3.5% in the forecast period of 2021-2026 to reach a value of nearly USD 4,393 million by 2026.

The recent success of angiotensin receptor blocker (ARB) drugs such as telmisartan can be attributed to the tentative utilisation of the drug in the treatment of COVID-19 infected patients. The clinical trials on people aged 18+ showed significant results in the treatment of COVID-19 with a lower median time to discharge, from 15 days to 9 days, reduction in deaths, and a substantial reduction in the requirement of ventilation, along with no side effects. The study suggested that the drug is safe and could reduce morbidity and mortality in critically infected patients. In addition to this, telmisartan is used for treating chronic diseases like hypertension, thereby lowering the risk of stroke and cardiac arrests, which is continually delivering a positive influence on the industry growth.

The presence of online healthcare platforms, including 1mg, Netmeds, and PharmEasy, are creating growth opportunities for the wide reach of telmisartan drugs. Telmisartan is popularly used to treat chronic diseases like hypertension and other cardiovascular diseases. In the presence of these online channels, companies like Nippon Boehringer Ingelheim, and Pfizer, Inc (NYSE: PFE). among others, are able to make their products available worldwide. Thus, the existence of online delivery channels is boosting the sales of telmisartan and hence augmenting the industry growth.

Market Analysis by Strength, Condition, Distribution Channel, and Region:

  • Based on strength, the market can be segmented into 20mg, 40mg, and 80mg.
  • The market, on the basis of condition, can be divided into hypertension, stroke, and cardiac arrest, among others.
  • On the basis of distribution channels, the market segmentations include hospital pharmacies, and retail pharmacies and drug stores, and online. 
  • The major regional markets for telmisartan are North America, Latin America, Europe, the Asia Pacific, and the Middle East and Africa. 

Key Findings of the Report:

  • The telmisartan industry is primarily being driven by the prevalence and risk of cardiovascular and other chronic diseases like hypertension. 
  • The development of generic versions of telmisartan to provide cost-effective treatment for hypertension and cardiac diseases is expected to propel the industry growth.
  • Significant contributions to study and explore the potential benefits of telmisartan in the treatment of kidney diseases are expected to augment market growth in the coming years. 
  • Clinical trials for the tentative treatment of COVID-19 infected patients and the positive results of the drug are providing impetus to market growth. 

Key Offerings of the Report:

  • The EMR report gives an overview of the telmisartan industry for the periods (2016-2020) and (2021-2026).
  • The report also offers historical (2016-2020) and forecast (2021-2026) markets for strengths, conditions, distribution channels, and regions of telmisartan.
  • The report analyses market dynamics, covering the key demand and price indicators in the market along with an assessment of the SWOT and Porter’s Five Forces Model.

The major players in the global telmisartan market are Novartis AG, Astellas Pharma Inc., Nippon Boehringer Ingelheim, Abbott, Hema Pharmaceuticals Pvt. Ltd., and Pfizer Inc, among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us:

Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports

Global Doxorubicin Market Report and Forecast 2021-2026





Global Nanomedicine Market Report and Forecast 2021-2026


NEWSLETTER